Current Technology Is Inadequate For Bioterrorism Response

Further, the study said, the need for clinicians to manually enter patients signs and symptoms into a diagnostic DSS is eliminated in a few systems that automatically collect patient data from an electronic medical record.

Unfortunately, the report added, none of the reports of diagnostic DSSs it reviewed dealt specifically with diseases arising out of bioterrorism events.

DSSs can be useful in other areas, providing treatment reminders, guidelines for certain diseases, correct dosages, and medication administration times, says Ortiz. In a bioterrorism situation in particular, he notes, DSSs could be “very helpful” in diagnosing and treating diseases that are otherwise rarely seen.

In the area of information management, Ortiz points out that “the majority of health care systems are still doing things in paper form,” adding that improvements are needed to “the infrastructure of the whole country” in order to effectively deal with bioterrorism.

“We need to start building in some specific bioterrorism pieces, and we have to start building and testing these systems in terms of bioterrorism effectiveness,” Ortiz states. “Dont just assume something is going to work. It could actually be bad and have unintended consequences.”

The study also examined reports on 55 detection systems “that collect and identify potential biothreat agents within environmental and clinical samples.” Most of these systems have been developed by the military, and there were few, if any, reports on their effectiveness, sensitivity and accuracy, the study said.

In addition, most of these systems test for only one bioterrorism agent and can only examine a limited number of samples at one time. The systems also “cannot test for many of the most worrisome agents (e.g., smallpox),” the study noted.

“Theres a lot we dont know about the military-developed systems,” says Ortiz. “The problem is that if you dont know what the biothreat is and your system only detects one thing, it might be something else. Ideally, we want to be able to detect multiple threats simultaneously.”

Chief among the barriers to better bioterrorism technology systems is the need for an updated infrastructure, a need that is not sufficiently funded, says Ortiz. “Public health systems arent awash in money. There are lots of budget cuts and competing priorities,” he explains.

“Now that we have the IT capability,” he continues, “we need to learn how to use it.” He adds that the case for funding of bioterrorism systems also needs the backing of health care organizations and academic health care leaders.

Ortiz notes that after the anthrax scares of 2001, the federal government doled out $1 billion to the 50 states to help them develop bioterrorism preparedness. He adds that in 2003, Health and Human Services “is supposed to be increasing that figure to $3 billion.”

How long will it take the U.S. to update its systems in order to be prepared to deal with bioterrorism? “Were more prepared now than we were a year ago,” says Ortiz. “Youre never really completely prepared, because bioterrorism is a rare and unexpected situation. The goal is to be as completely prepared as possible.”

Reproduced from National Underwriter Life & Health/Financial Services Edition, November 4, 2002. Copyright 2002 by The National Underwriter Company in the serial publication. All rights reserved.Copyright in this article as an independent work may be held by the author.